Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris

American Journal of Cardiology

Volumn 85, Issue 12, 2000, Pages 1414-1419

  Unger, Ellis F ^a   Goncalves, Lino ^a   Epstein, Stephen E ^a   Chew, Emily Y ^b   Trapnell, Carol Braun ^c   Cannon III, Richard O ^a   Quyyumi, Arshed A ^a   Stine, With The Technical Assistance Of Annette ^d   Loscalzo, Francis ^d   Stiber, Jonathan A ^d  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c Div Clin Trial Des Anal Ctr B   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ANGINA PECTORIS; ANGIOGENESIS; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTENSION; INTRACORONARY INFUSION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA;

EID: 18344417427     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00787-6     Document Type: Article

References (15)

1. Unger E.F., Banai S., Shou M., Lazarous D.F., Jaklitsch M.T., Scheinowitz M., Correa R., Klingbeil C., Epstein S.E. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 266:1994;H1588-H1595.
2. Harada K., Grossman W., Friedman M., Edelman E.R., Prasad P.V., Keighley C.S., Manning W.J., Sellke F.W., Simons M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 94:1994;623-630.
3. Lazarous D.F., Scheinowitz M., Shou M., Hodge E., Rajanayagam M.A.S., Hunsberger S., Robison W.G., Stiber J.A., Correa R., Epstein S.E., Unger E.F. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 91:1995;145-153.
4. Lazarous D.F., Shou M., Scheinowitz M., Hodge E., Thirumurti V., Kitsiou A.N., Stiber J.A., Lobo A.D., Hunsberger S., Guetta E., Epstein S.E., Unger E.F. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury in a canine model. Circulation. 94:1996;1074-1082.
5. Shou M., Rajanayagam S., Thirumurti V., Lazarous D.F., Quyyumi A.A., Goncalves L., Stiber J., Epstein S.E., Unger E.F. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs. J Am Coll Cardiol. 35:2000;519-526.
6. Cuevas P., Carceller F., Ortega S., Zazo M., Nieto I., Giménez-Gallego G. Hypotensive activity of fibroblast growth factor. Science. 254:1991;1208-1210.
7. Tiefenbacher C.P., Chilian W.M. Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation. Cardiovasc Res. 34:1997;411-417.
8. Schumacher B., Pecher P., von Specht B.U., Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors first clinical results of a new treatment of coronary heart disease . Circulation. 97:1998;645-650.
9. Sellke F.W., Laham R.J., Edelman E.R., Pearlman J.D., Simons M. Therapeutic angiogenesis with basic fibroblast growth factor technique and early results . Ann Thorac Surg. 65:1998;1540-1544.
10. Rosengart T.K., Lee L.Y., Patel S.R., Sanborn T.A., Parikh M., Bergman G.W., Hachamovitch R., Szulc M., Kligfield P.D., Okin P.M., Hahn R.T., Devereux R.B., Post M.R., Hackett N.R., Foster T., Grasso T.M., Lesser M.L., Isom O.W., Crystal R.G. Angiogenesis gene therapy phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease . Circulation. 100:1999;468-474.
11. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Maysky M., Ashare A.B., Lathi K., Isner J.M. Gene therapy for myocardial angiogenesis initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia . Circulation. 98:1998;2800-2804.
12. Panza J.A., Quyyumi A.A., Diodati J.G., Callahan T.S., Epstein S.E. Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing importance of the exercise protocol . J Am Coll Cardiol. 17:1991;657-663.
13. Whalen G.F., Shing Y., Folkman J. The fate of intravenously administered bFGF and the effect of heparin. Growth Factors. 1:1989;157-164.
14. Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., Vlodavsky I. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol. 130:1988;393-400.
15. Munaron L., Distasi C., Carabelli V., Baccino F.M., Bonelli G., Lovisolo D. Sustained calcium influx activated by basic fibroblast growth factor in Balb-c 3T3 fibroblasts. J Physiol (Lond). 484:1995;557-566.